
How Automation Speeds FDA Deficiency Letters Review
Is your regulatory team ready for the next FDA Deficiency Letters? FDA’s Center for Devices and Radiological Health (CDRH) reports over 55% of 510(k) submissions receive at least one Additional Information or Deficiency Letter—often due to missing data, unclear testing, or labeling issues. Across the product lifecycle, from preclinical to







